Defining priority medical devices for cancer management: a WHO initiative

被引:12
|
作者
Berumen, Adriana Velazquez [1 ]
Moyao, Gabriela Jimenez [3 ]
Rodriguez, Natalia M. [4 ,5 ]
Ilbawi, Andre M. [2 ]
Migliore, Antonio [6 ]
Shulman, Lawrence N. [7 ]
机构
[1] WHO, Essential Med & Hlth Prod, Geneva, Switzerland
[2] WHO, Management Noncommunicable Dis, Disabil Violence & Injury Prevent, Geneva, Switzerland
[3] Doctors Borders, Hosp Management Unit, Brussels, Belgium
[4] Univ Miami, Coll Arts & Sci, Inst Adv Study Amer, Florida, FL USA
[5] Univ Miami, Coll Arts & Sci, Dept Anthropol, Florida, FL USA
[6] Agenzia Nazl Serv Sanit Reg, Agenas, Rome, Italy
[7] Univ Penn, Abramson Canc Ctr, Philadelphia, PA 19104 USA
来源
LANCET ONCOLOGY | 2018年 / 19卷 / 12期
关键词
CLINICAL-PRACTICE GUIDELINES; CARE DECISION-MAKING; HEALTH; DIAGNOSIS; MULTICRITERIA; MEDICINES; HTA;
D O I
10.1016/S1470-2045(18)30658-2
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Medical devices are indispensable for cancer management across the entire cancer care continuum, yet many existing medical interventions are not equally accessible to the global population, contributing to disparate mortality rates between countries with different income levels. Improved access to priority medical technologies is required to implement universal health coverage and deliver high-quality cancer care. However, the selection of appropriate medical devices at all income and hospital levels has been difficult because of the extremely large number of devices needed for the full spectrum of cancer care; the wide variety of options within the medical device sector, ranging from small inexpensive disposable devices to sophisticated diagnostic imaging and treatment units; and insufficient in-country expertise, in many countries, to prioritise cancer interventions and to determine associated technologies. In this Policy Review, we describe the methods, process, and outcome of a WHO initiative to define a list of priority medical devices for cancer management. The methods, approved by the WHO Guidelines Review Committee, can be used as a model approach for future endeavours to define and select medical devices for disease management. The resulting list provides ready-to-use guidance for the selection of devices to establish, maintain, and operate necessary clinical units within the continuum of care for six cancer types, with the goal of promoting efficient resource allocation and increasing access to priority medical devices, particularly in low-income and middle-income countries.
引用
收藏
页码:E709 / E719
页数:11
相关论文
共 50 条
  • [1] WHO priority list of medical devices for cancer management
    Mayor, Susan
    LANCET ONCOLOGY, 2017, 18 (07): : 856 - 856
  • [2] World Health Organization List of Priority Medical Devices for Cancer Management to Promote Universal Coverage
    Ilbawi, Andre M.
    Velazquez-Berumen, Adriana
    CLINICS IN LABORATORY MEDICINE, 2018, 38 (01) : 151 - +
  • [3] REGULATION OF MEDICAL DEVICES Initiative in anaesthesia
    Pandit, Jaideep J.
    BRITISH MEDICAL JOURNAL, 2011, 342
  • [4] Defining the Building Blocks and the Priority Areas for Cooperation Under the Belt and Road Initiative
    Inusa, Yaktor Joshua
    Toe, Doris Hooi Chyee
    Yong, Kum Weng
    INTERNATIONAL JOURNAL OF BUILT ENVIRONMENT AND SUSTAINABILITY, 2021, 8 (02): : 115 - 126
  • [5] The Cancer Cell Map Initiative: Defining the Hallmark Networks of Cancer
    Krogan, Nevan J.
    Lippman, Scott
    Agard, David A.
    Ashworth, Alan
    Ideker, Trey
    MOLECULAR CELL, 2015, 58 (04) : 690 - 698
  • [6] Who's on first? - Medical discoveries and scientifc priority
    Markel, H
    NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (27): : 2792 - 2794
  • [7] Defining and characterizing task-shifting medical devices
    Sarvestani, Amir Sabet
    Coulentianos, Marianna
    Sienko, Kathleen H.
    GLOBALIZATION AND HEALTH, 2021, 17 (01)
  • [8] Defining and characterizing task-shifting medical devices
    Amir Sabet Sarvestani
    Marianna Coulentianos
    Kathleen H. Sienko
    Globalization and Health, 17
  • [9] Breast cancer gene: Who has priority?
    Santer, V
    AUSTRALASIAN BIOTECHNOLOGY, 1996, 6 (02) : 114 - 114
  • [10] DEFINING THE MANAGEMENT ROLE OF THE DEPARTMENT MEDICAL DIRECTOR
    BRADY, TF
    CARPENTER, CR
    HOSPITAL & HEALTH SERVICES ADMINISTRATION, 1986, 31 (05): : 69 - 85